Reduction of postprandial glucose by lixisenatide vs sitagliptin treatment in Japanese patients with type 2 diabetes on background insulin glargine: A randomized phase IV study (NEXTAGE Study)

AIM: To evaluate the pharmacodynamics of lixisenatide once daily vs sitagliptin once daily in Japanese patients with type 2 diabetes receiving insulin glargine U100. MATERIALS AND METHODS: This multicentre, open‐label, phase IV study (NEXTAGE Study; ClinicalTrials.gov number, NCT02200991) randomly a...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamada, Yuichiro, Senda, Masayuki, Naito, Yusuke, Tamura, Masahiro, Watanabe, Daisuke, Shuto, Yujin, Urita, Yoshihisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573929/
https://www.ncbi.nlm.nih.gov/pubmed/28345162
http://dx.doi.org/10.1111/dom.12945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573929/
https://www.ncbi.nlm.nih.gov/pubmed/28345162
http://dx.doi.org/10.1111/dom.12945

Ejemplares similares